Cargando…
Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells
ATC is a very rare, but extremely aggressive form of thyroid malignancy, responsible for the highest mortality rate registered for thyroid cancer. In patients without known genetic aberrations, the current treatment is still represented by palliative surgery and systemic mono- or combined chemothera...
Autores principales: | Allegri, Lorenzo, Capriglione, Francesca, Maggisano, Valentina, Damante, Giuseppe, Baldan, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347033/ https://www.ncbi.nlm.nih.gov/pubmed/34360846 http://dx.doi.org/10.3390/ijms22158083 |
Ejemplares similares
-
GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation
por: Molteni, Elisabetta, et al.
Publicado: (2023) -
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
por: Baldan, Federica, et al.
Publicado: (2015) -
Quercetin Protects Human Thyroid Cells against Cadmium Toxicity
por: Capriglione, Francesca, et al.
Publicado: (2021) -
Role of m6A RNA Methylation in Thyroid Cancer Cell Lines
por: Allegri, Lorenzo, et al.
Publicado: (2022) -
The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells
por: Allegri, Lorenzo, et al.
Publicado: (2019)